Samsara BioCapital's new venture partners from L-R: Alan Eisenberg, Eric Dobmeier and John Orwin

September 24, 2024 10:00 AM EDT

Samsara adds three venture partners to help steer and advise portfolio companies

Kyle LaHucik

Senior Reporter

Biotech investment firm Samsara BioCapital has added three new venture partners in recent months to expand its network, support first-time CEOs in its portfolio and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Samsara adds three venture partners to help steer and advise portfolio companies

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Updated: Gene therapy maker bluebird bio cuts costs again, lays off staff

Biogen, UCB declare Phase 3 lupus win and prep a second trial, but details are scant

Wave rides new Phase 2 DMD data as it sets sights on accelerated approval

Sanofi hires Mike Quigley as next chief scientist, internal memo says

Flagship’s AI biotech Generate lands $65M upfront in Novartis deal, as first clinical readouts near

PDCs vs. ADCs: A New Frontier in Targeted Cancer Therapies and the Potential for Development Partnerships

Sam­sara adds three ven­ture part­ners to help steer and ad­vise port­fo­lio com­pa­nies

Senior Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Samsara adds three venture partners to help steer and advise portfolio companies